Abstract:RNA aptamers are synthetic single stranded RNA oligonucleotides that function analogously to antibodies. Recently, they have shown promise for use in treating inflammatory skin disease as, unlike antibody-based biologics, they are able to enter the skin following topical administration. However, it is important to understand the inflammatory milieu into which aptamers are delivered, as numerous immune-modulating mediators will be present at abnormal levels. LL-37 is an important immune-modifying protein upregulated in several inflammatory skin conditions, including psoriasis, rosacea and eczema. This inflammatory antimicrobial peptide is known to complex nucleic acids and induce both inflammatory and interferon responses from keratinocytes. Given the attractive notion of using RNA aptamers in topical medication and the prevalence of LL-37 in these inflammatory skin conditions, we examined the effect of LL-37 on the efficacy and safety of the anti-IL-17A RNA aptamer, Apt 21-2. LL-37 was demonstrated to complex with the RNA aptamer by electrophoretic mobility shift and filter binding assays. In contrast to free Apt 21-2, LL-37-complexed Apt 21-2 was observed to efficiently enter both keratinocytes and fibroblasts by confocal microscopy. Despite internalization of LL-37-complexed aptamers, measurement of inflammatory mediators and interferon stimulated genes showed LL-37-complexed Apt 21-2 remained immunologically inert in keratinocytes, fibroblasts, and peripheral blood mononuclear cells including infiltrating dendritic cells and monocytes. The findings of this study suggest RNA aptamers delivered into an inflammatory milieu rich in LL-37 may become complexed and subsequently internalized by surrounding cells in the skin. Whilst the results of this study indicate delivery of RNA aptamers into tissue rich in LL-37 should not cause an unwarranted inflammatory of interferon response, these results have significant implications for the efficacy of aptamers with regards to extracellular vs. intracellular targets that should be taken into consideration when developing treatment strategies utilizing RNA aptamers in inflamed tissue.

LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs

Human host defense peptide LL-37 facilitates double-stranded RNA pro-inflammatory signaling through up-regulation of TLR3 expression in vascular smooth muscle cells

The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway

LL-37 and Double-Stranded RNA Synergistically Upregulate Bronchial Epithelial TLR3 Involving Enhanced Import of Double-Stranded RNA and Downstream TLR3 Signaling

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes

TLR3 Activation Efficiency by High or Low Molecular Mass Poly I:C.

LL-37 Transports Immunoreactive Cgamp to Activate STING Signaling and Enhance Interferon-Mediated Host Antiviral Immunity.

Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis

The toll-like receptor 3:dsRNA signaling complex.

Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids

Toll-like receptor 3 and its signaling pathway

Regulation Of Viral Infection-Induced Airway Remodeling Cytokine Production By The Tlr3-Egfr Signaling Pathway In Human Bronchial Epithelial Cells

Dual Functions of the Human Antimicrobial Peptide LL-37-target Membrane Perturbation and Host Cell Cargo Delivery.

Regulation of TLR3 Activation by S100A9

TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response

Antimicrobial Peptide LL-37 Facilitates Intracellular Uptake of RNA Aptamer Apt 21-2 Without Inducing an Inflammatory or Interferon Response

ZCCHC3 modulates TLR3-mediated signaling by promoting recruitment of TRIF to TLR3

Ro 90-7501 Enhances Tlr3 And Rlr Agonist Induced Antiviral Response

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Dimerization of Toll-like Receptor 3 (TLR3) Is Required for Ligand Binding